INTRODUCTION
Antibiotics are the most frequently prescribed drugs among hospitalized patients especially in intensive care and surgical department. Encouraging appropriate antibiotic prescriptions in health institutions is an important element in quality of care, infection control and cost containment 1 . The development of bacterial resistance to antibiotics has become a major problem throughout the world 2 . Antimicrobial resistance results in increased morbidity, mortality, and rising cost of health care 3, 4 . Monitoring of antimicrobial use and knowledge of prescription habits are some of the strategies recommended to contain resistance to antimicrobials in hospitalized patients. Our study focused in analyzing drug utilization pattern of Fluoroquinolones in the Medicine and Surgery wards of the hospital.
MATERIALS AND METHODS:
This study was carried out in the medicine and surgery wards of a 1000 bedded private tertiary care teaching hospital. The study was conducted for a period of seven months. Permission was obtained from Institutional Ethics Committee before starting the study. The data were collected from patients of all age groups from either sex, who got admitted to the medicine and surgery wards of the hospital.
A suitable data collection form was designed to collect and document the data. Data collection form includes demographic details of patient; drug therapy details (name of drug, dosage form, frequency, route of administration, duration of treatment) and length of stay. Data were collected from the patient's file on a daily basis.
Comparison of prescribed daily doses of FQs with defined daily doses was carried out using ATC/DDD Index 2013. The DDD/100 bed-days of all the FQs prescribed in the Medicine and Surgery ward was calculated. The DDD/100 bed-days of the individual FQs were added together to get the total FQ consumption.
The use of individual Fluoroquinolones and of the group as a whole was measured using the defined daily dose (DDD)/100 bed-days using the following formula 5 :
DDD/100 bed-days = No. of units administered in the study period (mg) x 100 DDD (mg) x No. of days in study period x No. of beds x bed occupancy Data of all the patients were analyzed with the help of Microsoft Access Data Sheet version 2010.
RESULTS:
We have enrolled 100 patients in the study who, were prescribed with FQs during the study period. It includes 67 males and 33 female patients. The majority of the patients (22%) were in the age group of 15-25 years followed by (19%) in the age group 56-65 years. The age wise distribution of the patients is presented in (Table 1) . 
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A total of 823 drugs were prescribed. The mean ± SD of drugs prescribed was 8.23 ± 3.33. For an individual patient, a particular drug prescribed by different brand names and administered by different routes was taken as a single drug for the purpose of calculation. The maximum number of patients (67%) was admitted in the Medicine wards and rest (33%) was admitted in the Surgery wards. The number of drugs prescribed per patient is presented in (Table 2) . Twenty patients were admitted for a period of 1 to 5 days, 37 patients for 6 to 10 days, 21 patients for 11 to 15 days, 10 patients for 16 to 20 days, 5 patients for 21 to 25 days and 7 patients for greater than 25 days. Mean ± SD duration of hospital stay was 11.54 ± 7.57 days.
Out of 100 patients 87 received FQs as monotherapy and 13 patients received multiple drug therapy. The agents prescribed as monotherapy in large numbers were Ciprofloxacin (54.02%) followed by Levofloxacin (31.03%). The commonly prescribed multiple drug therapy was Ciprofloxacin + Levofloxacin (53.84%). The details on the utilization of FQs as monotherapy and multiple drug therapy are presented in (Table 3 & 4) . FQ usage in both the wards during the study period was calculated in terms DDD/100 bed-days. In our study DDD/100 bed-days for FQs was found to be 33.55. Ciprofloxacin was the most frequently prescribed FQ (15.72 DDD/100 bed-days), followed by Levofloxacin (12.54 DDD/100 bed-days). The ATC code and the DDD/100 bed-days of the prescribed FQs are presented in (Table 5 ). (Table 6 ). All the FQs were prescribed by their brand names. It was also seen that the less costly standard brands were used. The maximum number of patients (67%) who received FQs was admitted in the Medicine wards, the rest (33%) were admitted in the Surgery wards.
In our study Ciprofloxacin was the most frequently prescribed FQ followed by Levofloxacin. This was in contrast to the study conducted in the United States where it was observed that there is an increase in the usage of Levofloxacin 6 . In our study DDD/100 bed-days for FQs was found to be 33.55. The DDD/100 bed-days of Ciprofloxacin and Levofloxacin was found to be 15.72 and 12.54 respectively. This indicates the highest utilization of Ciprofloxacin followed by Levofloxacin within the Medicine and Surgery wards of the hospital. A study conducted Gordana P et al, concluded that the overall FQ utilization was found to be 29.81 DDD/100 bed-days 7 . In another study it was found that parenteral ciprofloxacin was prescribed (82.643 DDD/100 BD) and parenteral Levofloxacin was prescribed (3.188 DDD/100 BD) 8 . In our study we found that parenteral Ciprofloxacin was (2.53 DDD/100 BD) whereas parenteral Levofloxacin prescribed was (3.11 DDD/100 BD).
During the study period one patient of age 15 years was found to be prescribed with FQs. A research on safety and efficacy of Ciprofloxacin in children in developing countries was reviewed by Green S et al, and they concluded that Ciprofloxacin was safe and efficacious 9 . However, it is better to be cautious while prescribing FQs in children due to conflicting reports. In our study location, there are no set of criteria for prescribing FQs in children and the decision to include the drug in the prescription is left to the individual physician. In an American study report, FQs were found to be the commonly prescribed drug for UTIs, sinusitis, skin infections and urinary tract infections 6 . In a previous study it was observed that Ciprofloxacin was mainly used to treat conditions like UTIs, chest infections, bacterial gastroenteritis, and bacteraemia 10 .
CONCLUSION:
The most common FQs prescribed were found to be Ciprofloxacin followed by Levofloxacin. We have observed the utilization of quinolone was higher than those reported in previous studies whereas the parenteral FQ utilization was less than those reported in previous studies. This is a good sign as injections are expensive, need of trained manpower and may also carry the risk of transmission of infections. We suggest that there is also a need of guidelines and policies regarding the use of FQs. This will effectively minimize the errors on the use of antibiotics which may promote rational drug use and better care on patients.
